Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:32 AM
Ignite Modification Date:
2025-12-25 @ 4:32 AM
NCT ID:
NCT02187718
Eligibility Criteria:
Inclusion Criteria:
* Female
* Age 18-60 years
* Diagnosis of invasive BC (established with core needle biopsy of the breast lesion)
* Breast carcinoma measures \> 20 mm ultrasonographically
* Pre-operative US+FNAC is negative or inconclusive
* No evidence of distant metastases
* ASA Classification I-III
* Signed informed consent
Exclusion Criteria:
* History of previous breast surgery in the affected breast
* History of previous axillary surgery in the ipsilateral axilla
* History of radiation therapy (ipsilateral breast or axilla)
* History of neo-adjuvant therapy (for the BC)
* Known allergy to lidocain
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT02187718
Study Brief:
Protocol Section:
NCT02187718